Naltrexone-bupropion for the treatment of binge eating disorder: a systematic review and meta-analysis
This meta-analysis found that naltrexone-bupropion has no significant benefits over placebo in reducing binge eating episodes or in improving metabolic or psychological outcomes. The possible effect on glycated hemoglobin levels warrants further investigation.
Authors
- Milene Vitória Sampaio Sobral (ORCID: https://orcid.org/0009-0001-5754-6472)
- Gilmara Peixoto Rister
- Maurício Prätzel Ellwanger (ORCID: https://orcid.org/0009-0002-8823-2588)
- Jordana Belgamasco Cavalcanti Marçal
Institutions
- Universidade do Oeste Paulista (BR)
- Universidade do Contestado (BR)
Publication Details
- Journal
- Brazilian Journal of Psychiatry
- Published
- 2025-01-01
- DOI
- https://doi.org/10.47626/1516-4446-2025-4258
- Primary Topic
- Eating Disorders and Behaviors
- Type
- article
- Field-Weighted Citation Impact
- 0.00